Tag: sanger sequencing market growth

  • How is the Sanger Sequencing Market Poised for Growth: Trends and Opportunities Through 2034

    How is the Sanger Sequencing Market Poised for Growth: Trends and Opportunities Through 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What key factors are powering the surge in the sanger sequencing market right now?

    The Sanger sequencing market has grown rapidly and is set to rise from $2.75 billion in 2024 to $3.3 billion in 2025 at a CAGR of 19.8%. Key growth drivers include increased research demand, expanding medical diagnostics, pharmaceutical advancements, agricultural applications, forensic analysis, biomarker discovery, and genetic evolution studies.

    How fast Is the sanger sequencing market expected to grow, and what’s its future value?

    The Sanger sequencing market is expected to grow rapidly, reaching $6.17 billion by 2029 with a CAGR of 16.9%. Growth will be driven by clinical genomics adoption, agricultural genomics expansion, increased drug safety measures, prenatal screening, and environmental DNA analysis. Trends include technological advancements, rising demand for next-generation sequencing, growing clinical diagnostic applications, increased genomics research investments, and expanding personalized medicine applications.

    Get your sanger sequencing market report here!

    https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

    What are the leading drivers of growth in the sanger sequencing market?

    The growth of the sanger sequencing market is anticipated to surge due to the increasing prevalence of genetic disorders. Genetic diseases, also known as genetic disorders, are health conditions resulting from anomalies or mutations in an individual’s DNA, which is the genetic material carrying the blueprint of life. Sanger sequencing is utilized to identify genetic disorders by accurately establishing the sequence of nucleotides, or DNA building blocks, in a specific gene or DNA region. For example, the National Health Service, a publicly funded healthcare system based in the UK, reported in August 2024, that around 2,300 individuals in the UK live with thalassaemia as of 2024. Among these individuals, about 800 suffer from the severe form of thalassaemia and require regular blood transfusions. Accordingly, the escalation in genetic disorders is encouraging the growth of the sanger sequencing market.

    What are the key segments defining the sanger sequencing market?

    The sanger sequencing market covered in this report is segmented –

    1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing

    2) By Laboratory: Wet Labs, Dry Labs

    3) By Research: In-House, Outsourced

    4) By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications

    5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics

    Subsegments:

    1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing, Metagenomic Shotgun Sequencing

    2) By Targeted Gene Sequencing: Amplicon Sequencing, Exome Sequencing

    3) By Other Sequencing: Nested PCR Sequencing, Sequencing By Synthesis (SBS)

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13925&type=smp

    Who are the key players steering the development of the sanger sequencing market?

    Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

    What emerging trends are influencing the growth of the sanger sequencing market?

    Leading firms in the Sanger sequencing market are channeling their efforts into extending their genomic lab facilities, aiming to provide speedy Sanger sequencing services across the North of the UK. These genomic laboratories engage in carrying out genetic tests and scrutinizing to learn about the organization, functioning, and transmission of genes and genomes, and are typically used for diagnostic purposes, research and individualized medicine. To illustrate, Source Genomics, a UK-based company that provides genomic services, revealed in June 2023, their plans to broaden their genomic laboratory to the North of the UK. This expansion will enhance the efficiency of their Sanger sequencing services, making data delivery faster, and implying a significant step toward ensuring fair access to genomic services for research institutions nationwide. This expansion will enable patrons from across the country to avail of superior Sanger sequencing services with more efficient delivery times.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13925

    Which regions are most influential in expanding the sanger sequencing market?

    North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Clinical Oncology Next Generation Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

    Whole Exome Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

    Short Read Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Sanger Sequencing Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights

    Sanger Sequencing Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Anticipated CAGR of the Sanger Sequencing Market, and What Factors Will Drive It?

    The market size of Sanger Sequencing has seen a significant expansion in the past few years. It is projected to rise from $2.75 billion in 2024 to $3.3 billion in 2025, witnessing a Compound Annual Growth Rate (CAGR) of 19.8%. The heightened growth during the previous period is associated with a surge in research needs, enhancement in medical diagnostics, escalation in pharmaceutical development, rise in agricultural usage, amplification in forensic analysis, and an increase in biomarker discovery and genetic evolution studies.

    The market size for Sanger sequencing is predicted to experience a swift expansion in the coming years, escalating to $6.17 billion by 2029, with a compound annual growth rate (CAGR) of 16.9%. This surge for the forecasted period is associated with factors like escalating application of clinical genomics, broadened genomics in agriculture, enhanced drug safety and pharmacogenomics, increased prenatal and infant screening, and a rise in environmental DNA analysis. Significant trends during this phase will feature technological developments, an escalated need for next-generation sequencing, expanded use in clinical diagnostics, increased funding in genomic research, and widespread use in personalized medicine.

    What Strategic Factors Are Influencing the Accelerated Growth of the Sanger Sequencing Market?

    The growth of the sanger sequencing market is anticipated to surge due to the increasing prevalence of genetic disorders. Genetic diseases, also known as genetic disorders, are health conditions resulting from anomalies or mutations in an individual’s DNA, which is the genetic material carrying the blueprint of life. Sanger sequencing is utilized to identify genetic disorders by accurately establishing the sequence of nucleotides, or DNA building blocks, in a specific gene or DNA region. For example, the National Health Service, a publicly funded healthcare system based in the UK, reported in August 2024, that around 2,300 individuals in the UK live with thalassaemia as of 2024. Among these individuals, about 800 suffer from the severe form of thalassaemia and require regular blood transfusions. Accordingly, the escalation in genetic disorders is encouraging the growth of the sanger sequencing market.

    Explore Comprehensive Insights Into The Global Sanger Sequencing Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13925&type=smp

    Who Are the Top Companies Contributing to the Growth of the Sanger Sequencing Market?

    Major companies operating in the sanger sequencing market report are:

    • Hoffmann-La Roche_x000D_

    • Thermo Fisher Scientific Inc._x000D_

    • Merck KGaA_x000D_

    • Eurofins Scientific_x000D_

    • Illumina Inc._x000D_

    How Are Technological Trends Affecting the Growth and Development of the Sanger Sequencing Market?

    Leading firms in the Sanger sequencing market are channeling their efforts into extending their genomic lab facilities, aiming to provide speedy Sanger sequencing services across the North of the UK. These genomic laboratories engage in carrying out genetic tests and scrutinizing to learn about the organization, functioning, and transmission of genes and genomes, and are typically used for diagnostic purposes, research and individualized medicine. To illustrate, Source Genomics, a UK-based company that provides genomic services, revealed in June 2023, their plans to broaden their genomic laboratory to the North of the UK. This expansion will enhance the efficiency of their Sanger sequencing services, making data delivery faster, and implying a significant step toward ensuring fair access to genomic services for research institutions nationwide. This expansion will enable patrons from across the country to avail of superior Sanger sequencing services with more efficient delivery times.

    Secure Your Global Sanger Sequencing Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

    Which Segments Play a Crucial Role in the Expansion of the Sanger Sequencing Market?

    The sanger sequencing market covered in this report is segmented –

    1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing

    2) By Laboratory: Wet Labs, Dry Labs

    3) By Research: In-House, Outsourced

    4) By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications

    5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics

    Subsegments:

    1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing, Metagenomic Shotgun Sequencing

    2) By Targeted Gene Sequencing: Amplicon Sequencing, Exome Sequencing

    3) By Other Sequencing: Nested PCR Sequencing, Sequencing By Synthesis (SBS)

    What Are the Key Regions Powering Growth in the Sanger Sequencing Market?

    North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    How Is the Sanger Sequencing Market Defined Across Different Regions?

    Sanger sequencing, or chain termination sequencing, is a method for determining the nucleotide sequence of DNA. Sanger sequencing is used for smaller-scale initiatives and for validating the outcomes of deep sequencing, as it can create DNA sequence reads of more than 500 nucleotides and maintain accuracy levels.

    Browse Through More Similar Reports By The Business Research Company:

    Clinical Oncology Next Generation Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

    Whole Exome Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

    Short Read Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Sanger Sequencing Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive Sanger Sequencing Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Sanger Sequencing Market from 2024 to 2033?

    The sanger sequencing market has expanded significantly in recent years, projected to increase from $2.29 billion in 2023 to $2.75 billion in 2024, with a compound annual growth rate (CAGR) of 19.9%. This growth is driven by rising research demand, enhanced medical diagnostics, pharmaceutical advancements, agricultural applications, forensic analysis, biomarker discovery, and genetic evolution studies.

    The sanger sequencing market is projected to experience significant growth, reaching $5.30 billion by 2028 at a CAGR of 17.8%. This growth is driven by the rising integration of clinical genomics, advancements in agricultural genomics, enhanced drug safety and pharmacogenomics, expanded prenatal and newborn screening, and increased environmental DNA analysis. Key trends include technological innovations, heightened demand for next-generation sequencing, broader applications in clinical diagnostics, increased investment in genomics research, and greater adoption in personalized medicine.

    Claim Your Free Sample of the Global Sanger Sequencing Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13925&type=smp

    What Key Factors Are Fueling the Growth of the Sanger Sequencing Market?

    The rise in genetic disorders is projected to drive the growth of the Sanger sequencing market. This method is essential for diagnosing genetic illnesses by determining the nucleotide sequences in DNA. The Genetic Rare Diseases Information Center noted about 7,000 known rare genetic diseases affecting approximately 30 million people in the U.S.

    What Are the Major Segments of the Sanger Sequencing Market?

    1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing

    2) By Laboratory: Wet Labs, Dry Labs

    3) By Research: In-House, Outsourced

    4) By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications

    5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics

    What New Trends Are Transforming the Sanger Sequencing Market?

    Companies in the sanger sequencing market are enhancing their systems to boost revenues. In October 2021, Promega Corporation introduced the ProDye Terminator Sequencing System, compatible with various capillary electrophoresis platforms.

    Order Now for Fast Delivery of Your Sanger Sequencing Market Report!

    https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

    Which Regions Are Driving Growth in the Sanger Sequencing Market?

    North America was the largest region in the sanger sequencing market in 2023. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Sanger Sequencing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the sanger sequencing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Sanger Sequencing Market Include

    1. Sanger Sequencing Market Executive Summary

    2. Sanger Sequencing Market Segments

    3. Sanger Sequencing Market Size And Template Market Growth Rate

    4. Key Sanger Sequencing Market Trends

    5. Major Sanger Sequencing Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Sanger Sequencing Market

    26. Top Sanger Sequencing Companies

    27. Sanger Sequencing Market Opportunities And Strategies

    28. Sanger Sequencing Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Clinical Oncology Next Generation Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

    NGS-Based RNA-Sequencing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

    Respiratory Disposables Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Overview Of The Sanger Sequencing Market 2024-2033: Growth And Major Players Analysis

    Overview Of The Sanger Sequencing Market 2024-2033: Growth And Major Players Analysis

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Market Size and Growth

    • 2023 Growth: The Sanger sequencing market reached $2.29 billion in 2023.
    • 2024 Projection: It is expected to grow to $2.75 billion in 2024, reflecting a compound annual growth rate (CAGR) of 19.9%.
    • 2028 Projection: By 2028, the market is projected to reach $5.30 billion, with a CAGR of 17.8%.

    Drivers of Historic Growth

    • Increased Research Demand: Growing research activities have fueled market expansion.
    • Medical Diagnostics: Rising use in medical diagnostics has boosted market size.
    • Pharmaceutical Development: Enhanced pharmaceutical development activities have contributed to growth.
    • Agricultural Applications: Expanded use in agriculture for crop improvement and disease resistance.
    • Forensic Analysis: Increasing forensic analysis needs.
    • Biomarker Discovery: Growing importance of biomarkers in personalized medicine.
    • Genetic Evolution Studies: Increasing studies on genetic evolution.

    View More On The Sanger Sequencing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

    Drivers of Future Growth

    • Clinical Genomics Integration: Enhanced integration in clinical genomics.
    • Agricultural Genomics Expansion: Broader applications in agricultural genomics.
    • Drug Safety and Pharmacogenomics: Rising importance in drug safety and pharmacogenomics.
    • Prenatal and Newborn Screening: Increasing use in prenatal and newborn screening.
    • Environmental DNA Analysis: Expanding applications in environmental DNA analysis.

    Major Market Trends

    • Technological Advancements: Continuous technological advancements in sequencing technology.
    • Next-Generation Sequencing Demand: Growing demand for next-generation sequencing.
    • Clinical Diagnostics Applications: Increased use in clinical diagnostics.
    • Genomics Research Investments: Rising investments in genomics research.
    • Personalized Medicine: Expanding use in personalized medicine.

    Impact of Genetic Illness Surge

    • Genetic Illnesses: Rise in genetic illnesses propels market growth.
    • Diagnostics: Sanger sequencing used for diagnosing genetic disorders.
    • Rare Diseases: Over 7,000 known rare genetic diseases, affecting 30 million people in the US.

    Key Companies in the Market

    • Hoffmann-La Roche
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Eurofins Scientific
    • Illumina Inc.
    • Beckman Coulter
    • PerkinElmer Inc.
    • BGI Group
    • LGC Limited
    • GenScript
    • Oxford Nanopore Technologies
    • Pacific Biosciences of California Inc.
    • Macrogen Inc.
    • GENEWIZ Inc.

    Advancements in Sanger Sequencing Technology

    • Promega Corporation: Launched the ProDye Terminator Sequencing System in October 2021.
    • System Features: Compatible with all capillary electrophoresis (CE) platforms, enhancing laboratory capabilities.
    • Technological Edge: Uses proprietary thermostable DNA polymerase for high efficiency.

    Strategic Acquisitions

    • QIAGEN and Verogen: In January 2023, QIAGEN acquired Verogen for $150 million.
    • Forensic Science: Strengthened leadership in forensic science.
    • Market Reach: Enhanced market-leading sample extraction and library prep automation capabilities.

    Market Segmentation

    • By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing.
    • By Laboratory: Wet Labs, Dry Labs.
    • By Research: In-House, Outsourced.
    • By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications.
    • By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics.

    Regional Insights

    • North America: Largest region in the Sanger sequencing market in 2023.

    The Sanger sequencing market is poised for significant growth, driven by technological advancements, expanding applications, and strategic acquisitions. With a strong presence in research, diagnostics, and personalized medicine, the market is set to transform various sectors, underscoring its critical role in advancing genomic science.

    Request A Sample Of The Global Sanger Sequencing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13925&type=smp